2017/0024(NLE)

Bio-based Industries Joint Undertaking: financial contributions

Awaiting committee decision

2017/0024(NLE) Bio-based Industries Joint Undertaking: financial contributions
RoleCommitteeRapporteurShadows
Lead ITRE
Opinion REGI BOGOVIČ Franc (EPP)
Lead committee dossier: ITRE/8/09337
Legal Basis TFEU TFEU 187, TFEU TFEU 188 -a1
Subjects
Links

Activites

  • 2017/04/03 Committee referral announced in Parliament, 1st reading/single reading
  • 2017/02/22 Legislative proposal published
    • COM(2017)0068 summary

Documents

History

(these mark the time of scraping, not the official date of the change)

2017-04-20
activities/0/docs/0/text added
  • PURPOSE: to amend Council Regulation (EU) No 560/2014 establishing the Bio-base Industries Joint Undertaking, in order to enable members of the Bio-based Industries Consortium to fulfil their obligation to contribute financially.

    PROPOSED ACT: Council Regulation.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council shall adopt the act after consulting the European Parliament but without being obliged to follow the opinion of the European Parliament.

    BACKGROUND: The Bio-based Industries Joint Undertaking (BBI JU) was established by Council Regulation (EU) No 560/2014 for the implementation of the Joint Technology Initiative on Bio-based Industries (the BBI JU initiative) until 31 December 2024. The BBI JU is a body responsible for the implementation of a public-private partnership whose members are, on the one hand, the Union, represented by the Commission, and, on the other hand, the Bio-based Industries consortium.

    The statutes of the Bio-based industries Joint Undertaking stipulate that the financial contribution to operational costs of the members of the Bio-based Industries Joint Undertaking, other than the Union, shall be at least EUR 182 500 000 up to 31 December 2024.

    The Bio-based Industries Consortium recognises its obligation to pay a financial contribution of at least EUR 182 500 000 before 31 December 2024, but it has found difficulties with the delivery mode.

    Many members of the Bio-based Industries consortium believe that it is not commercially viable to make a financial contribution at the programme level because this method does not guarantee any profits in return and that this could benefit competitors participating in projects funded by the Bio-based Industries JU. As a result, the Bio-based Industries consortium proposed a different method of payment of the financial contribution, namely the possibility for its members to pay directly at the project level.

    After assessing the Bio-based Industries Consortium’s proposal, the Commission intends to adjust Council Regulation (EU) No 560/2014 in order to remedy the difficulties faced by the consortium in paying its financial contribution under the current arrangements. The proposed change would not affect the original objectives.

    CONTENT: the Commission proposes to amend the Statutes of the Bio-based Industries Joint Undertaking by introducing a new method of payment of the financial contribution in addition to the existing method of payment.

    Concretely, the proposal:

    • introduces the possibility of making financial contributions in the following two ways: (i) transferring them from the consortium to the Bio-based Industries JU and / or (ii) transferring them directly from a member of the Bio-based Industries Consortium to another project beneficiary;
    • broadens the category of parties that could provide the financial contribution: in addition to the Bio-based Industries Consortium individually, its "constituent entities" (i.e. members of the consortium) would also be entitled to contribute financial resources;
    • maintains commitment to the overall financial objective of providing a financial contribution to operational costs of EUR 182 500 000 up until 31 December 2024;
    • allows members of the Bio-based Industries Consortium to declare through the latter the financial contributions they have made to the projects at the Bio-based Industries JU.

    This solution is similar to that agreed for the IMI2 Joint Undertaking (Innovative Medicines Initiative), in which members other than the Union may make financial contributions either at the programme or project level.

2017-04-08
2017-04-06
2017-03-25
2017-03-13
2017-03-12
2017-03-10

code AGPLv3.0+, data ODBLv1.0, site-content CC-By-Sa-3.0
© European Union, 2011 – Source: European Parliament